Oxybutynin Chloride Tablet, Extended Release
Product Images NDC 71335-2330

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Oxybutynin Chloride (NDC 71335-2330). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1 (Fig 1)

Figure 1 (Fig 1)
A line chart comparing mean plasma R-Oxybutynin concentration (ng/mL) over time (hours) for oxybutynin chloride extended-release tablets 10 mg once daily (QD) and oxybutynin 5 mg three times daily (TID). The chart shows concentration trends with error bars indicating variability at different time points up to 24 hours.*
FDA Label Image

Figure 2 (Fig 2)

Figure 2 (Fig 2)
A line graph depicting the mean R-Oxybutynin plasma concentration (ng/mL) over time (hours). The x-axis represents time from 0 to 24 hours, and the y-axis shows concentration ranging from 0 to 2 ng/mL. Data points with error bars illustrate plasma concentration levels at various time intervals up to 24 hours.*
FDA Label Image

Figure 3 (Figure 3)

Figure 3 (Figure 3)
A horizontal bar chart comparing data points for Oxybutynin Chloride Extended Release Tablets and a placebo. The chart includes a horizontal axis ranging approximately from -40 to 40, with plotted points and error bars for each group.*
FDA Label Image

Figure 4 (Figure 4)

Figure 4 (Figure 4)
A horizontal bar chart comparing oxybutynin and oxybutynin chloride extended-release tablets, showing a range on a horizontal axis with values spanning approximately from -40 to 40. The chart visually represents data points for both forms without specific numeric details.*
FDA Label Image

Figure 5 (Figure 5)

Figure 5 (Figure 5)
A chart comparing two data ranges labeled 'Oxybutynin chloride extended-release tablets' and 'oxybutynin'. The horizontal axis ranges approximately from -40 to 40, with the data points and error bars shown within negative and positive values. No specific data values or units are visible.*
FDA Label Image

Label (Lbl713352330)

Label (Lbl713352330)
Label for Oxybutynin Chloride Extended-Release Tablets USP 5 mg, oral tablets, repackaged by Bryant Ranch Prepack and manufactured by Unique Pharmaceutical Laboratories. The label displays NDC 71335-2330-1, package count of 30 tablets, storage instructions, and a barcode.*
FDA Label Image
Rising-logo (Rising Logo)
FDA Label Image

Structure (Structural Formula)

Structure (Structural Formula)
Chemical structure of Oxybutynin Chloride, showing the molecular arrangement with its functional groups and hydrochloride salt.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.